Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Multiple sclerosis: Could simvastatin slow down secondary progressive MS?
Do textured insoles effect postural control and spatiotemporal parameters of gait and plantar sensation in people with multiple sclerosis?
Tiliroside, a dietary glycosidic flavonoid, inhibits TRAF-6/NF-κB/p38-mediated neuroinflammation in activated BV2 microglia.
Integrated multi-cohort transcriptional meta-analysis of neurodegenerative diseases.
TIRC7 and HLA-DR axis contributes to inflammation in multiple sclerosis.
Multiple sclerosis: Pegylated IFN-β1a could lessen patients' injection burden.
A role for human brain pericytes in neuroinflammation.
Neurobehavioral and cytotoxic effects of vanadium during oligodendrocyte maturation: A protective role for erythropoietin.
Chronic Cerebrospinal Venous Insufficiency in Multiple Sclerosis: A Failed Concept.
Analysis of retinal nerve fibre layer, visual evoked potentials and relative afferent pupillary defect in multiple sclerosis patients.
Intrathecal CD4(+) and CD8(+) T cell responses to endogenously synthesized candidate disease-associated human autoantigens in multiple sclerosis patients.
Change of Th17 Lymphocytes and Treg/Th17 in Typical and Atypical Optic Neuritis.
Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis.
Integrative therapies for multiple sclerosis.
CCL5-glutamate interaction in central nervous system: Early and acute presynaptic defects in EAE mice.
Targeting ion channels for the treatment of autoimmune neuroinflammation.
Quantifying progression of multiple sclerosis via classification of depth videos.
Aerobic Fitness Is Associated with Inhibitory Control in Persons with Multiple Sclerosis.
Linking synaptopathy and gray matter damage in multiple sclerosis.
Multiple sclerosis: Activation of cortical microglia linked to level of disability in patients with multiple sclerosis.
Multiple sclerosis: Cognitive training provides lasting benefits for patients with multiple sclerosis.
Accelerometry as a measure of walking behavior in multiple sclerosis.
[Depression and neurological diseases].
Erythropoietin: new directions for the nervous system.
Acute necrotizing encephalopathy (ANE1): rare autosomal-dominant disorder presenting as acute transverse myelitis.
Pages
« first
‹ previous
…
425
426
427
428
429
430
431
432
433
…
next ›
last »